Ys Biopharma Co Stock Technical Analysis

YS Stock   1.02  0.11  12.09%   
As of the 26th of May, YS Biopharma owns the standard deviation of 7.25, and Market Risk Adjusted Performance of 1.05. Concerning fundamental indicators, the technical analysis model lets you check potential technical drivers of YS Biopharma, as well as the relationship between them. Strictly speaking, you can use this information to find out if the company will indeed mirror its model of historical prices and volume patterns, or the prices will eventually revert. We are able to interpolate and collect nineteen technical drivers for YS Biopharma, which can be compared to its peers in the sector. Please check out YS Biopharma downside deviation, treynor ratio, expected short fall, as well as the relationship between the variance and potential upside to decide if YS Biopharma Co is priced fairly, providing market reflects its prevailing price of 1.02 per share. Given that YS Biopharma is a hitting penny stock territory we urge to closely look at its total risk alpha.

YS Biopharma Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as YS Biopharma, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to YS Biopharma
  
YS Biopharma's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

YS Biopharma Analyst Consensus

Target PriceAdvice# of Analysts
5.1Strong Buy1Odds
YS Biopharma Co current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most YS Biopharma analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand YS Biopharma stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of YS Biopharma, talking to its executives and customers, or listening to YS Biopharma conference calls.
YS Biopharma Analyst Advice Details
YS Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of YS Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of YS Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

YS Biopharma Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of YS Biopharma volatility. High ATR values indicate high volatility, and low values indicate low volatility.

YS Biopharma Trend Analysis

Use this graph to draw trend lines for YS Biopharma Co. You can use it to identify possible trend reversals for YS Biopharma as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual YS Biopharma price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

YS Biopharma Best Fit Change Line

The following chart estimates an ordinary least squares regression model for YS Biopharma Co applied against its price change over selected period. The best fit line has a slop of   0.01  , which suggests that YS Biopharma Co will keep on generating value for investors. It has 122 observation points and a regression sum of squares at 1.52, which is the sum of squared deviations for the predicted YS Biopharma price change compared to its average price change.

About YS Biopharma Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of YS Biopharma Co on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of YS Biopharma Co based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on YS Biopharma price pattern first instead of the macroeconomic environment surrounding YS Biopharma. By analyzing YS Biopharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of YS Biopharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to YS Biopharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2021 2022 2023 2024 (projected)
Payables Turnover3.81.912.193.43
Days Of Inventory On Hand519.15441.21507.39534.83

YS Biopharma May 26, 2024 Technical Indicators

Most technical analysis of YS Biopharma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for YS Biopharma from various momentum indicators to cycle indicators. When you analyze YS Biopharma charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
When determining whether YS Biopharma is a strong investment it is important to analyze YS Biopharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact YS Biopharma's future performance. For an informed investment choice regarding YS Biopharma Stock, refer to the following important reports:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in YS Biopharma Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Complementary Tools for YS Biopharma Stock analysis

When running YS Biopharma's price analysis, check to measure YS Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy YS Biopharma is operating at the current time. Most of YS Biopharma's value examination focuses on studying past and present price action to predict the probability of YS Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move YS Biopharma's price. Additionally, you may evaluate how the addition of YS Biopharma to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Fundamental Analysis
View fundamental data based on most recent published financial statements
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
CEOs Directory
Screen CEOs from public companies around the world
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Is YS Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of YS Biopharma. If investors know YS Biopharma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about YS Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
9.461
Earnings Share
(0.57)
Revenue Per Share
4.67
Quarterly Revenue Growth
(0.09)
Return On Assets
(0.10)
The market value of YS Biopharma is measured differently than its book value, which is the value of YS Biopharma that is recorded on the company's balance sheet. Investors also form their own opinion of YS Biopharma's value that differs from its market value or its book value, called intrinsic value, which is YS Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because YS Biopharma's market value can be influenced by many factors that don't directly affect YS Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between YS Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if YS Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, YS Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.